The myeloma-developing regimens using genomics (MyDRUG) master protocol.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Daniel Auclair, Kenneth Carl Anderson, David Avigan, Giada Bianchi, Noa Biran, Maria Chaudhry, Hearn J. Cho, Maggie Furlong, Craig C. Hofmeister, Ankit J. Kansagra, Amrita Y. Krishnan, Jeremy Todd Larsen, Gregory Joshua Orloff, Ravi Vij, Peter Michael Voorhees, Andrew Jenho Yee, Jing Christine Ye, Jeffrey A. Zonder, Sagar Lonial, Shaji Kumar
Institutions: Multiple Myeloma Research Foundation, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Hackensack University Medical Center, MedStar Washington Hospital Center, Washington Hospital, Icahn School of Medicine at Mount Sinai, The Ohio State University, The University of Texas Southwestern Medical Center, City Of Hope National Medical Center, Mayo Clinic in Arizona, Washington University in St. Louis, Carolinas Healthcare System, Levine Cancer Institute, Massachusetts General Hospital, University of Michigan, The Barbara Ann Karmanos Cancer Institute, Winship Cancer Institute, Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2954847733